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Electron microscope images of human coronaviruses
Reality versus illusion
Ghallab MA1, Barsoum CH2, Polak S³, El Hassoun O3, Ghallab AM2,4
HPB and Liver Transplant Department, Queen Elizabeth Hospital, Birmingham, UK.
m.ghallab@nhs.net
ABSTRACT
Since the outbreak of COVID-19 as a pandemic disease earlier in 2020, several publications reported the
electron microscope images of SARS-CoV-2. This article reviews 73 articles from March 1956 till April 2021,
focusing on the ultrastructure characteristics of the viruses. We present the scientific debate and provide an
opinion on the current controversy of electron microscopic images interpreted as SARS-CoV-2 particles in
specimens from patients with COVID-19. Finally, we report our findings in a post-mortem lung specimen of
a COVID-19 patient. With this we hope to facilitate accurate interpretation of TEM findings, and contribute to
the building of a unified database in the face of COVID-19 (Tab. 2, Fig. 8, Ref. 81). Text in PDF www.elis.sk
KEY WORDS: electron microscope, TEM, coronaviruses, SARS-CoV-2, COVID-19.

Abbreviations: Human coronaviruses (hCoV), Student code
number 229E (229E), Organ culture 43 (OC43), Netherlands
63 (NL63), Hong Kong University 1 (HKU1), Severe acute respiratory syndrome-coronavirus (SARS-CoV), Middle East respiratory syndrome-coronavirus (MERS-CoV), Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), Coronavirus
disease-2019 (COVID-19), Transmission electron microscope
(TEM), Hematoxylin and eosin (HE), Infectious bronchitis virus (IBV), Human ciliated airway epithelial cell (HAE), Vero
E6 cell (African green monkey embryonic kidney cells), Bronchial alveolar lavage (BAL), The National Institute of Allergy
and Infectious Diseases, USA (NIAID), The Centers for Disease Control and Prevention, USA (CDC), Double-membrane
vesicle (DMV).
Introduction
Identification of viruses using electron microscopy is based on
their variable and distinct morphologies (1). At the beginning of a
viral outbreak, it is important to identify the virus type and assess its
novelty. This determines which approaches are better for detecting
the causative agent, what helps in controlling its transmission and
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limiting the potential consequences of the epidemic (2). Electron
microscopy is an essential tool for the proper identification and
study of coronaviruses based on their ultrastructural characteristics
(3). “Corona” is a Latin word meaning crown, coronaviruses got
this designation due to the presence of crown like spike peplomers
surrounding viral particles as seen in negative stain preparations
for the electron microscope (4). Currently, there are seven documented strains of coronavirus which cause infection in humans
(human coronaviruses or hCoV), four of which usually cause mild
cold-like symptoms. The first prototypic strain, hCoV-229E (alpha
genera) was grown on standard tissue culture in 1967 (5, 6). The
second was isolated using tracheal organ culture and found to be
distinct from hCoV-229E, so it was named OC43 (beta genera) (7,
8). Early this century, two more hCoVs also causing mild symptoms
were identified. In 2004, hCoV-NL63 (alpha genera) was isolated
from the aspirate of a case with bronchiolitis in the Netherlands
(9), while hCoV-HKU1 (beta genera) was isolated in Hong Kong
from a patient with pneumonia in 2005 (10). There are, however,
three more serious strains of hCoVs that were discovered during
the 21st century, which cause severe acute respiratory illness or
even death. These are; severe acute respiratory syndrome-coronavirus (SARS-CoV (beta genera)) in 2002–2003 (11), Middle East
respiratory syndrome-coronavirus (MERS-CoV (beta genera)) in
2012 (12) and severe acute respiratory syndrome-coronavirus-2
(SARS-CoV-2 (beta genera)) in 2019–2020 which is the cause of
coronavirus disease-2019 (COVID-19) (2, 13–19).
This article reviews the ultrastructural characteristics of the
different strains of human coronaviruses with focus on the SARSCoV-2, provides an opinion of the current debate concerning the
presence of virus or virus-like particles in various organs and
presents HE and TEM findings in lung samples of a post mortem
case of COVID-19 pneumonia.
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Materials and methods

reports were published concerning electron microscopic images
of SARS-CoV-2, at a rate of almost one publication per week.

Since the outbreak of the COVID-19 pandemic, several publications reported electron microscopic images of SARS-CoV-2.
Through a Google and Pubmed search, we reviewed 73 articles
dealing with the ultrastructure of coronaviruses from March 1956
till April 2021, including author correspondence. We present the
building of current body of knowledge on coronaviruses from an
electron microscopic point of view, including the recent controversy on the interpretation of presence of SARS-COV-2 virus/virus
like particles in various organs. Based on our knowledge of the
difficulty in demonstrating viral particles in autopsy specimens, we
decided to test our hypothesis on lung tissue from a post mortem
case with antigen-confirmed COVID-19 pneumonia. Lung tissue
was taken from the right and left lung, upper and lower lobes. All
tissue was processed for standard HE histology and TEM.
Morphology of Coronaviruses
Nine articles from the second half of the last century studied
two known hCoVs at that time, hCoV-299E and hCoV-OC43.
Twelve articles described electron microscopic images of the other
two coronaviruses which cause cold-like symptoms, hCoV-NL63
and hCoV-HGU1. Twenty of the reviewed articles investigated
electron microscope images SARS-CoV and MERS between
2003 and 2019. Finally, during 2020, more than forty articles and
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Fig. 1. (A) HCoV-229E particles within dilated vesicles of rough endoplasmic reticulum, 80 - 100 nm in diameter. X61,600 (5). © Permission License Number 4905830317744. (B) Negative stained hCoVOC43 virus showing characteristic “club-shaped” surface projections.
Bar = 100 nm (8). (C) HCoV-NL63 particles surround the base of
two cilia (arrows) of HAE culture ×146,000 (30). © License Number
4944370304842. (D) HAE infected with HCoV-HKU1 showing the
presence of the large numbers of virions (circled) associated with the
surfaces of ciliated cells. Scale bar = 2 μm (31). © Permission License
Number 4936301017887.

hCoV-229E
During the second half of the 20th century, ultrastructure of the
infectious bronchitis virus (IBV) strains in chicken was examined
by transmission electron microscope (TEM) with negative staining technique. The particles were circular in shape with diameter
between 80 and 120 nm. Most of these particles had spike-like
projections on the surface, attached to the virus by a narrow neck
and sometimes forming a bulbous mass. Based on this, it was
suggested that the infectious bronchitis virus was similar to the
influenza virus in size and shape (7, 20–22). The 229E virus was
isolated from an acute specimen obtained during an upper respiratory infection and was named after a student specimen coded
229E at the University of Chicago. It was cultured on WI-38 human diploid fibroblasts and was examined by thin section TEM.
The viral particles were spherical, 80 to 100 nm in diameter, and
contained a “hollow” or electron-transparent central area 35 to 50
nm in diameter. Virions were seen inside dilated vesicles and cisternae of rough endoplasmic reticulum (Fig. 1A) (5). There were
some similarities observed between the 229E and IBV initially in
organ cultures inoculated with specimens from human respiratory
illnesses. However, examination after positive staining in ultrathin
sections revealed a difference in their internal structure (6). The
characteristic club-like structures around the particles which were
readily apparent by negative staining were at times also visible in
thin sections (23). Recent electron microscopic studies showed
that hCoV-229E was spherical in shape with a diameter of 80 to
120 nm and with the nucleocapsid diameter from 9–13 nm. Virions
were demonstrated inside dilated vesicles and cisternae of rough
endoplasmic reticulum (24).
hCoV-OC43 (B814)
The B814 strain was isolated from nasopharyngeal wash of
a patient with the common cold and grown in tracheal organ cultures and consequently was named OC43. In electron microscopic
images, viral particles showed an overall diameter of 160 nm and
characteristic spikes 20 nm in length (Fig. 1B) (7, 8). HCoV-OC43
was morphologically indistinguishable from CoV-226E and IBV,
and patients infected with the virus presented similar clinical symptoms as that of 229E, with no serological cross-reactivity between
both strains (25–27). Another strain of coronavirus similar to OC43
was detected using immune electron microscopy in organ culture
harvests derived from a bronchial washing from an adult with an
acute upper respiratory tract disease (28).
hCoV-NL63
In 2003, a novel virus was isolated from a child suffering
from respiratory disease in the Netherlands. The virus was isolated and grown on a monkey kidney cell line and identified as
hCoV-NL63 (29). The virus particles were successfully visualized
in hCoV-NL63 infected human ciliated airway epithelial (HAE)
cell cultures using TEM (30). The viral particles were seen in the
cell cytoplasm close to the apical supranuclear region and inside
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Reference

hCoV-229E

Virus

72 hrs

3–5 days

human ciliated airway epithelial
cells

Vero E6 cell, bronchial alveolar
lavage (BAL)

throat swab centrifuged.
Negative stained particles
undetermined

nasopharyngeal oropharyngeal
swab day 3 post symptom onset 2–3 days?
inoculated on Vero cells.
Nasopharyngeal and oropharyngeal swab and sputum
48 hrs after
samples from symptomatic
inoculation
patients inoculated on Vero cells

bronchoalveolar lavage inoculated on HAE, negative stained
virus particles
6 days

5–6 days

monkey kidney cells, human
ciliated airway epithelial cells

Vero E6 culture

4 days

6–72 hrs

70–80 nm

70–90 nm

hollow 30–35nm

Centre

spherical particles with
club-like projections
emanating from the viral
membrane

Spherical particles with
club shaped viral projections, average 14 nm in
length

Spherical with halo

electron dense

electron dense

Spherical with cobbled
surface structure having
envelope projections
ending in round ‘peplomeric’ structures, averaged 15±2 nm

cells in culture ranged
from healthy to necrotic

Morphologically
identical to 229E

Comment

Not applicable

patient tested with PCR

wide range of intracellular organelles, sequencing, particles
especially in vesicles
determined by size.

PCR and sequencing

Extracellular free virus particles and
inclusion bodies filled with virus
PCR and sequencing
particles in membrane bound vesicles
in cytoplasm

extracellularly near the plasma membrane, intracellularly inside cisternae
of endoplasmic reticulum

extracellular associated with ciliae
and in cytoplasm in small vesicles
outer surface of plasma membrane,
nucleocapsids in the rough endoplasmic reticulum/Golgi region and on
the outer layer of nuclear envelope,
nucleocapsids seen as black dots
were seen in membrane-bound vesicles
double-membrane vesicles and
nucleocapsid inclusions

Extracellularly around ciliae and in
cytoplasm in apical supranuclear
region and in rough ER

viewed in negative staining

vesicles and ER cisternae

Location

electron dense granules
extracellular spherical particles
(nucleocapsid)

spherical

spherical

lucent with electron
dense granules

electron-lucent

spherical, core either
Spherical, long clubclear, with electron
shaped, spikes 10–20 nm dense granules, or
totally electron dense

Spherical, Club shaped
spike projections
Club shaped spikes of
20 nm

Shape and surface

60 to 140 nm spikes, about 9 to 12 nm

78 mean

75–115,
mean 100

160

80–100

Time after
Diameter nm
inoculation

tracheal organ culture

fibroblast culture

Visualised on

Tab. 1. Virus particle morphology for each type of coronavirus with emphasis on SARS-CoV-2.
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rough endoplasmic reticulum cisternae. In addition, hCoV-NL63
particles were seen surrounding the base of HAE cell cilia (Fig.
1C) (9, 30).
hCoV-HKU1
In 2005 the human coronavirus HKU1was first discovered
in an elderly patient, hospitalized with pneumonia and bronchiolitis, in Hong Kong (10). Human ciliated airway epithelial cell
(HAE) cultures were used to grow hCoV-HKU1 successfully for
the first time in vitro (31). To confirm the cellular localization of
hCoV-HKU1, HAE cultures were inoculated with the isolated virus for 72 hours and then processed for TEM. Viral particles were
observed in large amounts in association with the apical cilia and
relatively fewer amounts were seen inside vesicles in the cytoplasm of HAE (Fig. 1D) (31). Most patients that were infected
with hCOV-HKU1 presented with symptoms of respiratory tract
infections (10, 26, 32, 33).
SARS-CoV
The WHO announced an outbreak of severe acute respiratory
disease in China in November 2002. The novel virus causing this
disease was termed severe acute respiratory syndrome coronavirus
(SARS-CoV) (2, 34). Isolated viral samples from diseased patients
in different countries were grown in Vero E6 cell (African green
monkey embryonic kidney cells) cultures and examined by TEM
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Fig. 2. (A) SARS-CoV particles with nucleocapsids appearing as black
dots in infected Vero E6 cells seen budding into membrane-bound
vesicles [35]. (B) SARS-CoV–infected cell with viral inclusion bodies
(arrow) double-membrane vesicles (open arrow) and nucleocapsid
inclusions (arrowhead). Bar = 100 nm. (35). © Permission from C.
Goldsmith. Transmission electron micrographs of MERS-CoV particles in infected Vero E6 culture cells found (C) extracellularly and
(D) intracellularly (39). © Free permission.

(3, 11). Large clustered viral particles measuring 80–140 nm in
diameter with peripheral surface projections (20 nm) were identified adherent to the outer surface of the plasma membrane (3).
Electron microscopic examination of cell cultures and of bronchial
alveolar lavage (BAL) specimen identified viral nucleocapsids in
the rough endoplasmic reticulum/Golgi region and on the outer
layer of nuclear envelope. Spherical or occasionally pleomorphic
virions acquired their envelope through budding into the cisternae
of the endoplasmic reticulum. In infected Vero E6 cells SARSCoV particles with nucleocapsids seen as black dots were seen in
membrane-bound vesicles (Fig. 2A). SARS-CoV–infected cells
showed double-membrane vesicles and nucleocapsid inclusions
(Fig. 2B) (35, 36).
MERS-CoV
Another virulent human coronavirus emerged in the Middle
East and was named Middle East respiratory syndrome coronavirus (MERS-CoV) (15, 37). This virus was first detected in 2012
from the lungs of a patient who died from severe respiratory disease. Since its discovery, clusters of secondary outbreaks have
occurred due to the exportation of cases through travel (12, 33,
37, 38). The National Institute of Allergy and Infectious Diseases,
USA (NIAID) and The Centers for Disease Control and Prevention (CDC) produced images of MERS coronavirus particles using
TEM. Transmission electron micrographs of MERS-CoV particles
found virions extracellularly near the plasma membrane of an infected Vero E6 culture cells and intracellularly inside cisternae of
endoplasmic reticulum (Fig. 2C, D) (39, 40).
SARS-CoV-2
The WHO announced the outbreak of a novel coronavirus-2019 in Wuhan, China, with exportation to other countries in
January 2020 (41). On March 11, 2020, the WHO declared coronavirus disease-2019 (COVID-19) a global pandemic, making
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
the first human coronavirus to cause a pandemic (42). A brief summary of this novel virus and disease was provided with references
to the previously known SARS-CoV and MERS (2, 15, 16, 37,
43). In January 2020, Zhu and his colleagues published the first
electron microscopic image of the virus isolated from the first
patient in China (13). Electron microscopic images of the virus
then were published from Korea (45), India (46), and the USA
(44) The CDC published images of the virus isolated from the
first USA COVID-19 patient in (47) (Fig. 3A). In February 2020,
NIAID produced images of SARS-CoV-2 from the same patient
using both scanning and transmission electron microscopes (48).
In all the above papers, SARS-CoV-2 infection was confirmed
by PCR and/or sequencing methods. Specimens were collected
from patients respiratory secretions and grown in cell cultures;
HAE in (13) and various strains of Vero cells in (44, 45, 46) (Figs
3B, 4B). Virus particle morphology was demonstrated using negative TEM staining in (13, 46, 49) and is summarised in Table 1.
Cell culture specimens were taken for electron microscopy at
various intervals ranging from day 2 to 6 post infection. In HAE
cultures, SARS-CoV2 particles were identified on the apical sur903

Bratisl Med J 2021; 122 (12)
900 – 911

A

B

C

D

Fig. 3. (A) TEM image of SARS-CoV-2 isolated from the first U.S. case
of COVID-19. The viral particles, contain cross-sections through nucleocapsids, seen as dark dots (47). © Free Permission. TEM images
showing SARS-CoV-2 particles isolated and grown in a cell culture
inoculated with infected patient nasopharyngeal and oropharyngeal
fluids, showing extracellular spherical particles (B) with cross sections
through the nucleocapsid, seen as black dots and intracellular particles (C,D) with a membrane coat around viral particles (44, 50, 51).
© (B&C) Free Permission and (D) License Number 4916430084114.

The induction of myelin like membrane wholes within the
same vacuoles as the core particles in Vero E6 infected with SARSCoV was described by (11). They also described the presence of
electron dense donut shaped particles interpreted as the virus genome, either singly or in clusters of few particles enclosed in small
vesicles in the cytoplasm or associated with the myelin-like figures
(24) described the presence of lamellar bodies in infected type II
alveolar epithelial cells (57) described vacuolisation of epithelial
cells as a sign of viral infection.
SARS-CoV-2 particles by TEM, are they reality or illusion?
Many investigators claimed to have identified SARS-CoV-2 in
biopsy or autopsy specimens from various organs of COVID-19
deceased patients. Post- mortem samples demonstrating virus like
particles were taken from the lung, heart and kidney and examined
with TEM (54-57. Purported virus particles were also shown in
skin biopsies from COVID-19 patients (58), and were also demonstrated in lung, trachea, kidney and large intestine (62, 64). These
findings however, have been challenged by scientists who argue
that the particles seen in different organs are either misinterpreted
or artefacts in electron microscopic images (50, 51, 59–63) (Fig. 5).
Details of these papers and their responses are shown in Table 2.
Originally, the authors argued that the difference noticed in
viral morphology by TEM can be attributed to a different virus
activation/replication state or to the degeneration of the tissue and
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face of both ciliated and secretory cells (Fig. 4A) and later inside
both cell types, which as opposed to other types of coronaviruses
is an evidence of its mutlicellular tropism (49).
SARS-CoV2 morphogenesis in cell cultures
Inclusion bodies were formed by viral components into pleomorphic double-membrane vesicles (DMVs). This description was
identical to previous findings in both SARS-CoV and MERS-CoV
(3, 13, 35, 48, 49). Spherical viral particles contained cross-sections
through the nucleocapsids seen as black dots. Aggregates of virus
particles were found in membrane- bound areas in the cisternae of
the rough endoplasmic reticulum and Golgi complex, where the
spikes would be located on the inside of the cisternae (Fig. 3C, D)
(50, 51) . TEM images demonstrated that SARS-CoV-2 entered
cells through membrane fusion instead of endocytosis (24). Mature
SARS-CoV-2 particles were released from the plasma membrane
into the extracellular space when the smooth vesicles containing
virions fused with the cell membrane (Fig. 4C, D) (24, 52). Several similarities in TEM images suggested that the life cycle of
SARS-CoV-2 and SARS-CoV could be identical (11, 24, 52, 53).
Cytopathic effects of SARS CoV2
Changes in the ultrastructure of SARS-CoV2 HAE infected
cells included the appearance of DMV, aggregates of denaturated
mitochondria, enlarged apical ER, ciliae shrinkage and immobility (49).
904

Fig. 4. (A) Infected HAE with SARSCoV-2 showing vesicles full of viral
particles in ciliated cells and on the outer cell surface close to cilia (49).
© Permission Free. (B) Thin section electron micrographs of Vero cells
infected with SARS-CoV-2 showing aggregates of assembled intracellular virions (45). © Permission from corresponding author MyungGuk Han. (C) Electron micrograph of Vero E6 cells infected with
SARS-CoV-2 showing extracellular virus particles released outside
the plasma membrane. Scale bars: 500 nm. (52). © Free permission.
(D) Thin section electron micrographs of Vero E6 cells infected with
a SARS-CoV-2-positive throat swab sample showing intracellular and
extracellular viral particles. Bar = 500 nm. (24). © Permission Free.

Day 6

Kissling et al (56) biopsy

Post
mortem

biopsy

Farkash et al (57)

Colmenero et
al (58)

Su etl al (64)

Post
mortem

Post
Bradley et al (62)
mortem

Day 8

Post
mortem

Varga et al
(55)

Immunohistochemistry, TEM

Light microscopy,
TEM

Light microscopy,
immunofluorescence,
TEM

Light microscopy,
Lung, trachea,
immunohistokidney, large
chemistry, TEM,
intestine
RT-PCR

Not
kidney
mentioned

4 and 7
days

Day 11 of Acral skin
symptoms lesions

PM kidney
proximal
tubules

kidney

Light microscopy
and TEM

endothelial
cells of various organs

Day 8

Post
mortem

Pesaresi et al (54)

1. Virions in extracellular vesicle, close to lung
smooth muscle.
2. Intracellular virions in vesicles or associated to
internal membrane (Fig 5b)
3. Virions in the cardiomyocytes adjacent to
myofibrils
4. In renal epithelial tubular cell
kidney tissue with viral inclusion bodies in a peritubular space and viral particles in
endothelial cells of the glomerular capillary loops.
(Fig. 5A)

Findings

1. Intracellular viruses arranged into arrays, suggestive of intracellular manufacture and assembly.
2. Presence of double membrane vesicles with
possible viral assembly.
3. Vacuolation of epithelial cells after infection
Virus-like particles in membrane-bound structures
within the cytoplasm of endothelial cells.
(Fig. 6C)
Virions in tracheal epithelial cells, lung
pneumocytes (Fig. 5D), enterocytes, and kidney
endothelial cells and proximal tubular epithelial
cells. Virions observed either outside cells, in
close proximity to the cell membrane or inside the
cells in aggregates confined within vesicles. Some
particles were associated with double membranes
resembling double membrane vesicles.
Virus-like particles in cytoplasm of renal
proximal tubular epithelium (Fig. 5C), in
podocytes, less so in distal tubules
adjacent double membrane with surface
projections, nucleocapsid apposing to the viral
envelope, and the interior electron-lucent of the
particles

Light microscopy, Vacuoles containing numerous spherical
immunofluoresparticles that may correspond to viral inclusion
cence, PCR, TEM bodies in the podocyte cytoplasm (Fig 6D)

TEM

heart kidney
and lung

Specimen
type

Author

Methodology in
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Sampled
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Time
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Tab. 2. Details of papers describing SARS-CoV-2 particles in various organs and challenging correspondence.

Goldsmith et al
(50)

Bullock et al (72)

Response

ribosomes on
rough endoplasmic
reticulum

Multivesicular bodies,
rough endoplasmic
reticulum, undifferentiated structures

Suggested
interpretation

Clathrin coated
Goldsmith et al (51)
vesicles, multivesicular
Bullock et al (72)
bodies

Direct evidence of the invasion
Clathrin coated
Miller et al (59),
of SARSCoV-2 into kidney
vesicles, multivesicular
Calomeni et al (61)
tissue
bodies

pathogenetic role for
Clathrin coated
SARS-CoV-2 in chilblains
Brealey et al (63)
vesicles
presenting during the pandemic
1. Diffuse alveolar damage is
the major source of pulmonary
injury
2. No evidence of widespread
Dittmayer et al (68) Multivesicular bodies
microvascular injury.
3. Possibility of extrapulmonary
involvement in renal, intestinal,
cardiac, and lymphoid tissues

Direct viral involvement in
acute renal injury of COVID-19 patients

Direct viral toxicity in
Miller et al (59),
podocytes and tubular cells
Bullock et al (72), Multivesicular bodies
both of which harbor the ACE2
Calomeni et al (61)
receptor

SARS-CoV-2 induces
endothelitis in several organs
by directviral involvement

Virus enters cells of various
organs

Conclusion
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Fig. 5. (A) Electron microscopy of kidney endothelial cell from postmortem autopsy of COVID-19 case, alleging to show viral inclusion bodies
in peritubular space consistent with capillary containing purported
viral particles. (55). © Permission License number 4918930272360. (B)
TEM image from lung autopsy of COVID-19 positive case purporting
to show viral particles associated to internal membranes. Bar = 400 nm.
(54). © Permission Free. (C) Ultrastructural features of kidneys from
post-mortems of patients with COVID-19. Non-viral structures with
distinctive spikes were present in the proximal tubular epithelium. (64).
© Permission License Number 4916361209448. (D) Purported SARSCoV-2 particles in kidney endothelial cells. Spherical structures were
observed inside the cells in aggregates confined within double membrane vesicles (62). © Permission License Number 4924131458105.

cytolytic activity due to the release of lysosomal content (54). Several authors replied to the challenges, pointing out that challenging
authors have studied coronavirus isolates grown in cell cultures
(65), as opposed to routine EM processing of autopsy tissues under
markedly different conditions (67). They underlined that they considered the identified structures to be possible, but not definitively
proven, SARS-CoV-2 particles and changed the description in the
preprint version article of “viral particle” to “coronavirus-like particle (64, 65, 67). Authors argued that it remains unclear to what
extent tissue type (cell culture, fresh biopsy material, or autopsy
material), time to fixation, and post-mortal autolysis alter subcellular structures in preparation for EM (65), and emphasized that
their findings point to a general host inflammatory response and
could explain the vascular microcirculatory complications seen in
different organs in patients with COVID-19 (65).
In agreement with the above mentioned dissenting opinions
(50, 51, 59), more investigators (61, 68, 69) also disagreed with
the interpretation and findings the above articles (54, 55, 58, 62,
64) and claimed that the electron microscopic images in those
publications showed insufficient ultrastructural features of SARSCoV-2. They concluded that not all apparent crowns are coronas
and that some of these particles definitely represented clathrincoated vesicles seen in podocytes, endothelial cells of the parietal glomerular epithelium, or multivesicular bodies (MVB), for
906

which they offered images (Fig. 6A, B) (61, 68, 69), this time using
samples taken from autopsies (60, 68) and kidney biopsies (61,
69). Possible explanations of these misinterpretations include the
varied size of MVB, ranging from 20 to 500 nm due to fusion of
lysosomes with pinocytotic vesicles. In addition, Clathrin coated
vesicles may give the false appearance of crown-like structures on
electron microscopy. Therefore, images should show clear distinct
ultrastructural features of SARS-CoV-2 particles and not just viruslike particles. It was concluded that examination of kidney biopsies
by electron microscopy from patients with COVID-19-associated
acute kidney injury, showed no evidence of direct SARS-CoV-2
infection (Fig. 7A, B, C, D) (60, 69).
Undisputed viral particles were demonstrated in the olfactory
mucosa in individuals who died in the context of COVID-19 (70,
71). Bullock et al (72) published yet another extensive review of articles presenting structures misinterpreted for coronavirus particles.
They also presented coronavirus images prepared from a deparaffinized sample after identification of the infected area using immunohistochemistry in autopsy tissue, with obvious compromise to
viral particle morphology. They argued, that the presence of large
numbers of intracellular and extracellular uniformly sized particles
in areas corresponding to positive immunostaining or molecular
labelling are clues to the presence of viruses. Members of the
same team also published a guidance for identifying coronaviruses
by TEM, including a description of mimicking organelles (73).
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Fig. 6. (A) Multivesicular body in a podocyte of a patient with lupus
nephritis who tested negative for COVID-19 (61). Bar = 100 nm. ©
Permission License Number 4916960920151. (B) Renal biopsy from
a patient with COVID-19 showing a podocyte containing a multivesicular body. (69). Bar = 100 nm. © Permission License Number
4924190150506. (C) Ultrastructural image from skin biopsy of an endothelial cell showing alleged coronavirus-like particles (arrow). Bar
= 200 nm. (58). © Permission License Number 4924150616654. (D)
Podocytes cytoplasmic vacuoles containing numerous spherical vesicles
measuring between 50 to 110 nm and surrounded by spikes measuring
9 to 10 nm. These particles have been purported to correspond to viral
inclusion bodies reported with the emerging SARS-CoV-2. Bar = 200
nm. (56). © Permission License Number 4916420955619.
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Fig. 7. (A) Renal biopsy from a patient positive for SARS-CoV2; showing endothelial cell containing a clathin-coated vesicle with a “corona”
65 nm in diameter (white arrow); bar = 100 nm. (B) Renal biopsy from
a patient not infected with SARS-CoV2, showing an endothelial cell
containing identical structures (white arrow); bar = 100 nm. (C) Native renal biopsy from a patient with COVID-19 showing podocyte
containing a microvesicular body/autophagosome (bar = 100 nm). (D)
Renal biopsy from a patient not infected with SARS-CoV2 showing
microvesicular body in a podocyte (bar = 100 nm). (69). © Permission
License Number 4924190150506.

The recent review by Hopfer et al (74) aimed at combining
multidisciplinary expertise of SARS-CoV-2 pathology, virology
and electron microscopy. It emphasized that understanding virus
biology is key for correct TEM interpretation. They offered TEM
images of various stages of viral infection in culture cells and their
morphological mimickers. The authors describe an area of convoluted membranes in an infected Vero cell as a sign of past viral
replication, and present an image of an infected Vero cell with a
replication organelle (74). Snijder et al (75) presented an extensive
study of the replication of several types of coronaviruses in cell
cultures, demonstrating convoluted membranes as a prominent
element of beta coronavirus replication organelle.

Histology of the lungs showed acute interstitial pneumonia,
proliferation of type II pneumocytes with marked cytopathic effect (Fig. 8A), alveolar spaces were filled with edema, hyaline
membranes, epithelial cells and macrophages. A focal moderate
lymphocytic infiltrate was seen in the interstitial space and some
vessels contained microthrombi. In TEM, epithelial cells showed
marked cytoplasmic vacuolisation (Fig. 8B), with abundant myelin like structures or lamellar bodies, in addition to dilation and
disruption of rough endoplasmic reticulum (Fig. 8C). Few cells
contained a system of membranes and vesicles in the perinuclear
region which are suggestive of a replication complex. Fine browsing of the cytoplasm occasionally showed aggregates of convoluted membranes (Fig. 8D). Epithelial cells contained few undenaturated organelles, mostly in the perinuclear region. We did not
demonstrate any viral particles in our material. Viable endothelial
cells present in the specimen did not show signs of ultrastructural
alteration or damage.
Our opinion
The article by Kissling et al (56) was criticized claiming that
electron microscopy was the only alleged evidence presented in
support of presence of virions in kidney tissue, while all other
tests were negative (59). Carefully reading Kissling et al (56); the
authors performed PCR for SARS-CoV-2 in sampled specimen
and not only in the patient respiratory tract. Even though it came
out negative, they point at the known limited rate of detection in
nonrespiratory samples, and the poor quality of the extracted RNA
material. They also performed immunofluorescence and excluded
the presence of immune deposits to rule out other mechanisms.
A

B

C

D

Our case
An 83-year-old male with multiple comorbidities and one week
history of flu symptoms with confirmed COVID-19 infection by
antigen test was admitted to the hospital for severe unproductive
cough, fever and progression of lower limb edema. Examination
showed COVID-19 pneumonia with possible bacterial superinfection and cardiac decompensation in both circulations. The patient
was treated with low flow oxygen, corticoids, antibiotics, diuretics and anticoagulants. Despite treatment, the patient continued to
deteriorate and died on day 3 of hospitalization. Autopsy was performed the next day and samples were taken for standard HE histology and TEM. Specimens were processed for semithin sections
and stained with toluidine blue to confirm presence of pneumocytes
with cytopathic effect before proceeding with ultrathin sections.

Fig. 8. Post mortem lung specimen from COVID-19 patient showing
(A) proliferation of type II pneumocytes (asterisk) with marked cytopathic changes, HE. Bar = 50 μm. (B) Pneumocyte showing marked
vacuolisation of the cytoplasm, N = nucleus. (C) formation of myelin
like structures or lamellar bodies = LM, associated with double membrane vesicles in the cytoplasm. Asterisk shows dilated and disrupted
rough endoplasmic reticulum. (D) system of membranes and vesicles
in the perinuclear region suggestive of a replication organelle = RO in
perinuclear region, N = nucleus. Arrow shows aggregates of convoluted
membranes associated with past viral replication.
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The authors explained that their hypothesis was based on the fact
that observed morphologic changes in the kidney occurred with no
obvious systemic injury. That is; acute tubular necrosis developed
in the absence of hemodynamic compromise or severe pulmonary
involvement, and collapsing focal segmental glomerulosclerosis
(FSGS) occurred in a patient with normal levels of cytokines,
in particular interleukin-6. The authors went the extra mile and
showed that the patient was homozygous for the at-risk apolipoprotein A (APOL1) G1 variant (A342G and I348M), a recognized
risk factor for the development collapsing FSGS in HIV and nonHIV patients. In our point of view, this report is an example of
meticulous multidisciplinary approach with careful clinicopathological correlation and substantiated hypotheses.
Authors demonstrated immunohistochemical evidence of caspase in damaged tissue in COVID-19 patients as an indicator of
apoptosis (55). Caspase is responsible for cleavage of several
proteins involved in clathrin-mediated endocytosis, halting cargo
uptake as part of the mechanisms of cell death (76). For this reason, we doubt the presence of an excessive amount of Clathrin
coated vesicles in such an advanced stage of cell death as shown
in figure 3a, b of (57). In our humble opinion, particles demonstrated in (64) are not in keeping with multivesicular bodies as
interpreted in the (61) letter to the editor, as they are not bound
by a limiting membrane.
Bradley et al (62) supported their findings by detecting SARSCoV-2 RNA in lung, trachea, subcarinal lymph node, kidney, large
intestine, spleen, liver, heart, and blood of patients sampled for
TEM. They also demonstrated immunohistochemical positive
staining of SARS-CoV-2 spike protein in renal tubular epithelium.
Likewise, Colmenero et al (58) demonstrated positive granular
staining of the spike protein in the cytoplasm of endothelial cells
by immunohistochemistry. Although the spike protein is considered
rather a safe antigen for immunohistochemistry, with described
cross-reactivity only with other similar viral spike proteins (77),
positive staining might not confirm the presence of entire viral particles (78) demonstrated discordant negative spike protein staining
by RNA ISH in cases with positive immunohistochemistry for the
same protein. They suggested that cleaved spike protein may be
deposited in endothelial cells and eccrine epithelium as a potential
pathogenic mechanism of COVID-19 endotheliitis.
The lack of unequivocal evidence of virus particles in biopsy or
postmortem specimens is not a proof that the virus was not there.
A study of SARS-CoV2 shedding kinetics using cell cultures and
PCR demonstrated a median shedding duration of 8 days post
symptom onset, with drop below 5 % on day 12.5 (79). Taking this
into consideration, in addition to factors compromising specimen
quality, such as time to autopsy and tissue processing techniques,
it is not surprising to find no evidence of viral particles. An extensive analysis comparing the presence of the virus with regard to
time the specimen was taken after symptom onset, proof of infection and biopsy or post mortem is warranted. An attempt for such
analysis will be limited due to poor and variable documentation
of these facts within different reports.
Very few of the reviewed articles make reference to cytopathic
ultrastructural changes in coronavirus infected cells (11, 24, 49,
908

57). In our material, these changes were immense, and corresponded to the cytopathic changes observed in HE. We believe
that a demonstration of ultrastructural cytopathic changes post viral
infection should be considered another tool for determining the
population of affected cells, while bearing in mind structural alterations caused by apoptosis, necrosis and autolysis. The latter, could
provide an explanation of the lack of significant abnormalities in
endothelial cells in our specimen, where injured endothelial cells
could have perished or disintegrated beyond recognition. Evidence
of endothelial dysfunction with relation to COVID-19 infection in
the literature is indisputable (80, 81), and the pathomechanisms
involved are almost certainly multipronged. Meaning that the lack
of evidence of viral particles within endothelial cells does not exclude viral induced injury.
Nowadays, virus detection by TEM is rarely used in routine
setting, as it is expensive, time-consuming, covers minute portions of the tissue, and is not available in most laboratories (72).
However, TEM is still an essential tool and a front-line evaluation method in the search for unknown pathogens in outbreaks
or epidemics (67). In studies of infectious diseases, TEM is still
considered the gold standard to prove the presence of an infectious unit. It allows the exact localisation of viruses in tissues and
within cells. This, in turn allows the determination of target cells
of virus infection and informs about the reproduction of the virus
(68). Virus visualisations using harvesting methods are excellent
in purifying viruses from a sample and yielding a good amount
for TEM. However, by using this method cellular and intracellular
visualization and characterisation is lost. Finally, one of the limitations of working with cell cultures is the lack of host response analyses after viral infection, nevertheless, the results should improve
the understanding of viral transmission and pathogenesis (49).
Conclusion
This article reviewed the available body of knowledge on the
ultrastructure of coronaviruses and presented the scientific debate
on the interpretation of TEM images of SARS-CoV-2 particles in
biopsies or autopsies and their mimickers. Comparison between
the two should facilitate accurate interpretation.
Demonstration of viral particles is not an easy task. It depends
on a large number of variables, including time of inoculation,
symptom onset, patient underlying conditions, genetic predisposition, choice of treatment and sampling parameters. In pandemic
circumstances, scientists are under immense pressure to produce
fast results in short time. Finding viral particles in various organs
and tissues emerged as the holy grail of many researchers, with less
attention paid to the biology of infected cells and virus replication
mechanisms. We believe that a multifaceted approach should be
adopted for the evaluation of any specimen, taking into consideration available clinicopathological correlations. Our suggestion
for authors who were not able to demonstrate viral particles, but
still have a good reason to believe in direct viral involvement, is
to pursue ultrastructural changes in cells which are in keeping
with post viral infection.
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